Qiu Y, Hui H W, Cheskin H
Pharmaceutical and Analytical Research Division, Abbott Laboratories, North Chicago, Illinois 60064-2204, USA.
Pharm Dev Technol. 1997 Aug;2(3):197-204. doi: 10.3109/10837459709031439.
The purpose of this paper was to develop a hydrophilic matrix system for extended oral delivery of zileuton, and study the effects of certain formulation, processing, and dissolution variables on in vitro drug release. Tablet formulations with 60-70% drug and varying release rates were prepared by wet granulation using low and medium viscosity grades of hydroxypropylmethocellulose. In vitro drug release was evaluated using USP apparatus 1. The in vitro drug release from all formulations followed zero-order kinetics and was independent of compression force. In general, the release rate decreased with increasing drug load and higher polymer concentration or viscosity. High-shear granulation also resulted in lower release rate. Accelerated release was observed with increased agitation as well as in the dissolution media with higher surfactant concentration and/or ionic strength. No stereoselective release from the matrix system was observed. The hydrophilic matrix system effectively controlled the in vitro release of zileuton. Matrix tablets with desired release rates can be prepared by adjusting various formulation and processing parameters. The matrix system also has the advantage of simple processing and relatively low cost.
本文的目的是开发一种用于齐留通口服缓释的亲水基质系统,并研究某些制剂、工艺和溶出变量对体外药物释放的影响。采用低、中粘度等级的羟丙基甲基纤维素通过湿法制粒制备了含药量为60 - 70%且释放速率不同的片剂制剂。使用美国药典装置1评估体外药物释放。所有制剂的体外药物释放均符合零级动力学,且与压力无关。一般来说,释放速率随药物负载量增加以及聚合物浓度或粘度升高而降低。高剪切制粒也导致较低的释放速率。随着搅拌增加以及在表面活性剂浓度和/或离子强度较高的溶出介质中观察到加速释放。未观察到基质系统的立体选择性释放。亲水基质系统有效地控制了齐留通的体外释放。通过调整各种制剂和工艺参数可以制备出具有所需释放速率的基质片剂。该基质系统还具有工艺简单和成本相对较低的优点。